scholarly article | Q13442814 |
P2093 | author name string | Elizabeth R Fischer | |
Jeffrey I Cohen | |||
Mir A Ali | |||
Qingxue Li | |||
P2860 | cites work | Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread | Q24307918 |
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor | Q24322090 | ||
The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells | Q24523691 | ||
Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0 | Q24647866 | ||
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family | Q28295196 | ||
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. | Q30657750 | ||
Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells | Q31019030 | ||
The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions | Q33785316 | ||
The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread | Q33798798 | ||
Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins | Q33812868 | ||
The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors | Q33987514 | ||
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse | Q34069075 | ||
The complete DNA sequence of varicella-zoster virus | Q34162480 | ||
Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane | Q34349663 | ||
Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector | Q34793366 | ||
Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection | Q35101360 | ||
Absence or overexpression of the Varicella-Zoster Virus (VZV) ORF29 latency-associated protein impairs late gene expression and reduces VZV latency in a rodent model | Q35635351 | ||
Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells. | Q35892356 | ||
The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor | Q35947774 | ||
Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication | Q36099097 | ||
Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread | Q36424473 | ||
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells | Q36626714 | ||
Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters | Q36645576 | ||
Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy | Q36688025 | ||
Use of a glucocorticoid-inducible promoter for expression of herpes simplex virus type 1 glycoprotein gC1, a cytotoxic protein in mammalian cells | Q36756929 | ||
Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection | Q36780794 | ||
Deletions in herpes simplex virus glycoprotein D define nonessential and essential domains | Q36805631 | ||
Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus | Q36825917 | ||
Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. | Q36869202 | ||
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties | Q36899072 | ||
Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo | Q37596576 | ||
Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth | Q39550597 | ||
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. | Q39642417 | ||
Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread | Q39700393 | ||
Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells | Q39753125 | ||
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking | Q39882103 | ||
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI | Q40065898 | ||
Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope | Q40478161 | ||
Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells | Q40843597 | ||
The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans | Q41035870 | ||
Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. | Q41100044 | ||
Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin | Q42594535 | ||
The acidic amino-terminal region of varicella-zoster virus open reading frame 4 protein is required for transactivation and can functionally replace the corresponding region of herpes simplex virus ICP27. | Q42669460 | ||
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures | Q44564031 | ||
The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells | Q45729694 | ||
Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody | Q45774660 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infectivity | Q1662346 |
P1104 | number of pages | 10 | |
P304 | page(s) | 270-279 | |
P577 | publication date | 2009-02-23 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection | |
P478 | volume | 386 |
Q35081168 | A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients |
Q33591823 | Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection |
Q36825131 | Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine |
Q34389074 | Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system |
Q33622464 | Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability |
Q39782339 | Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum. |
Q37633252 | Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk |
Q35076854 | Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells |
Q33640129 | Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses |
Q37256702 | Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis |
Q35776521 | Simian varicella virus gene expression during acute and latent infection of rhesus macaques |
Q36145800 | The varicella-zoster virus genome |
Q39214502 | Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis |
Q37547741 | Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44 |
Search more.